Contraception
📧 Sign up to get email alerts when something new happens for Contraception.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-03-11FDA Approved: NIKKI — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for NIKKI, a generic drospirenone/ethinyl estradiol combination oral contracept…
-
CLINICAL_TRIALS trial_result · 2019-03-11Clinical Trial Update: Online Peer Influence on IUD Behaviors and Attitudes [NA]
Clinical trial on online peer influence related to intrauterine device (IUD) behaviors and attitudes has completed with results posted.
-
FDA approval · 2019-01-24FDA Approved: LOJAIMIESS — Supplemental Application (Xiromed LLC)
FDA approved a supplemental application for LOJAIMIESS, a combination oral contraceptive manufactured by Xiromed LLC.
-
CLINICAL_TRIALS trial_result · 2019-01-18Clinical Trial Update: Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring and Levonorgestrel-Ethinyl Estradiol Combined Oral Contraceptive in Adult Women at Risk for Pregnancy (MK-8342B-062) [Phase 3]
Phase 3 trial evaluating two contraceptive regimens—the etonogestrel/17β-estradiol vaginal ring and the levonorgestrel/ethinyl estradiol ora…
-
CLINICAL_TRIALS trial_result · 2019-01-11Clinical Trial Update: Early Postpartum Intrauterine Device (IUD) Placement [Phase 4]
Phase 4 clinical trial update on early postpartum intrauterine device placement; study terminated with posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-01-03Clinical Trial Update: LARC Forward Contraceptive Counseling at MHCC [Phase 4]
Phase 4 clinical trial update for LARC Forward contraceptive counseling study; terminated with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2018-12-31Clinical Trial Update: Vaginal Misoprostol Before Intrauterine Contraceptive Device Insertion [Phase 3]
Phase 3 trial updating on vaginal misoprostol before intrauterine contraceptive device insertion.
-
CLINICAL_TRIALS trial_result · 2018-12-31Clinical Trial Update: Impact of Combined Hormonal Contraceptives on UPA [Phase 4]
Phase 4 trial updated results on the impact of combined hormonal contraceptives on ulipristal acetate (UPA).
-
FDA approval · 2018-12-07FDA Approved: DROSPIRENONE AND ETHINYL ESTRADIOL — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for DROSPIRENONE AND ETHINYL ESTRADIOL from Mylan Pharmaceuticals Inc., enabling the generic oral co…
-
CLINICAL_TRIALS trial_result · 2018-11-19Clinical Trial Update: Patient-Centered Support for Contraceptive Decision-Making [NA]
A completed clinical trial focused on patient-centered support for contraceptive decision-making; results posted in 2018.
-
FDA approval · 2018-11-05FDA Approved: NORETHINDRONE ACETATE — Original Application (Ingenus Pharmaceuticals, LLC)
FDA approved the original application for norethindrone acetate, allowing Ingenus Pharmaceuticals, LLC to market a generic norethindrone ace…
-
CLINICAL_TRIALS research · 2018-11-02Clinical Trial Update: Computerized Contraceptive Decision Aid [NA]
A completed clinical trial evaluating a computerized contraceptive decision aid, with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-10-03Clinical Trial Update: Innovative Model of Patient-Centered ConTraception [NA]
A completed clinical trial update on an innovative patient-centered model of contraception; results posted in 2018.
-
FDA approval · 2018-09-26FDA Approved: BLISOVI FE 1/20 — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin's supplemental application for BLISOVI FE 1/20, a generic oral contraceptive containing norethindrone acetate and ethinyl…
-
CLINICAL_TRIALS trial_result · 2018-09-26Clinical Trial Update: Oral Ketorolac for Pain Relief During IUD Insertion [Phase 4]
Phase 4 clinical trial evaluating oral ketorolac for pain relief during IUD insertion has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2018-08-31Clinical Trial Update: Intervention to End Recurrent Unscheduled Bleeding Trial [Phase 3]
Phase 3 clinical trial completed for an intervention aimed at ending recurrent unscheduled bleeding in contraception-related settings; resul…
-
CLINICAL_TRIALS trial_result · 2018-07-26Clinical Trial Update: Safety and Expulsion of Delayed Versus Immediate Postpartum Intrauterine Device Placement [NA]
A terminated clinical trial evaluating safety comparing delayed versus immediate postpartum intrauterine device placement for contraception.
-
CLINICAL_TRIALS trial_result · 2018-07-12Clinical Trial Update: Nexplanon and Combined Oral Contraceptive (COC) Combined Use Study [Phase 4]
Phase 4 clinical trial updating the combined use of Nexplanon and combined oral contraceptive (COC) for contraception; study completed with …
-
FDA approval · 2018-06-13FDA Approved: DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM AND LEVOMEFOLATE CALCIUM — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' generic version of a combined oral contraceptive containing drospirenone, ethinyl estradiol and levomefo…
-
FDA approval · 2018-06-05FDA Approved: HAILEY 1.5/30 — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved HAILEY 1.5/30, a generic combination oral contraceptive containing norethindrone acetate and ethinyl estradiol, under ANDA for …
-
FDA label_change · 2018-05-29FDA Approved: NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a labeling supplement for a combined oral contraceptive containing norethindrone acetate, ethinyl estradiol, and ferrous fumara…
-
CLINICAL_TRIALS trial_result · 2018-03-13Clinical Trial Update: Timing of Postpartum Depot Medroxyprogesterone Acetate Administration on Breastfeeding, Contraceptive Continuation, and Depression [Phase 4]
Phase 4 clinical trial evaluating timing of postpartum depot medroxyprogesterone acetate on breastfeeding, contraceptive continuation, and d…
-
FDA approval · 2018-02-27FDA Approved: DROSPIRENONE AND ETHINYL ESTRADIOL — Original Application (NorthStar Rx LLC)
FDA approved the original application for a generic drospirenone/ethinyl estradiol product (DROSPIRENONE AND ETHINYL ESTRADIOL) manufactured…
-
CLINICAL_TRIALS trial_result · 2018-02-05Clinical Trial Update: "E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study" [Phase 1, Phase 2]
Clinical trial update for an E4/DRSP endocrine and metabolic study in contraception and liver metabolism; completed Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2018-01-29Clinical Trial Update: Connecting Healthy Women: Examining the Effect of an Intervention From the Effect of Being Reachable [NA]
Clinical trial completed; results posted in 2018 for an intervention related to contraception and sexually transmitted infections.